In a 34‑year‑old patient with a 12‑year‑old porcine aortic valve and suspected von Willebrand disease, is a transcatheter valve‑in‑valve (ViV) procedure feasible or is open‑heart surgical replacement required, and will the scheduled CT scan determine candidacy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can You Do Valve-in-Valve with a Pig Valve, or Do You Need Open Heart?

Yes, you can absolutely do valve-in-valve (ViV) with your porcine (pig) bioprosthetic valve—you don't necessarily need open heart surgery, but the CT scan will determine if you're anatomically suitable for the transcatheter approach. 1

Understanding Your Options

You have two main pathways for replacing your failing 12-year-old porcine aortic valve:

1. Transcatheter Valve-in-Valve (ViV) Procedure

  • This is a catheter-based approach where a new valve is placed inside your old pig valve through blood vessels (usually through your groin)
  • For severely symptomatic patients with bioprosthetic aortic valve stenosis and high or prohibitive surgical risk, a transcatheter ViV procedure is reasonable when performed at a Comprehensive Valve Center 1
  • The VIVID registry showed that within 1 month after ViV, 7.6% of patients died and 1.7% had major stroke, with 93% of survivors experiencing good functional status 1
  • One-year survival rate was 83.2% 1

2. Surgical Aortic Valve Replacement (Open Heart)

  • Traditional open-heart surgery to remove the old valve and place a new one
  • Cumulative survival rates are actually higher with reoperative surgical AVR than with transcatheter ViV treatment 1
  • Surgery is associated with reduced incidence of patient-prosthesis mismatch, reduced paravalvular leak, and lower aortic valve gradients 1
  • For patients with a bioprosthetic or mechanical prosthetic valve, repeat surgical intervention is indicated unless surgical risk is high or prohibitive 1

Why the CT Scan Matters

Yes, you absolutely need that CT scan before deciding—it's not optional. Here's what it evaluates:

  • Valve anatomy: Annulus size and shape, leaflet calcification, coronary ostial height 2
  • Vascular anatomy: Whether your femoral/iliac arteries can accommodate the catheter delivery system 1, 2
  • Aortic root anatomy: Presence of dilation that would require surgical replacement 2
  • Risk of coronary obstruction: The most feared complication of ViV TAVR 3
  • Distance between sternum and heart: Important if surgery is needed to avoid injury during re-do sternotomy 4

The Age Factor in Your Case (34 Years Old)

This is critically important: At 34 years old, you're significantly younger than typical ViV candidates. Here's why this matters:

  • Valve durability is paramount at your age—you need a valve that will last decades
  • Current guidelines recommend surgical AVR for adults <65 years of age unless life expectancy is limited by comorbidities 2
  • Long-term (20-year) data on surgical bioprosthetic valves are available; robust data on transcatheter bioprosthetic valves extend only to 5 years 1, 2
  • Your 12-year-old pig valve lasted about as expected (10-12 years in younger patients) 5
  • If you get another bioprosthetic valve via ViV now, you'll likely need another intervention in 10-15 years—and you could be looking at multiple reinterventions over your lifetime

Your Von Willebrand Disease Consideration

This is actually relevant to your decision:

  • Most patients with severe aortic stenosis develop acquired von Willebrand syndrome due to shear stress on the von Willebrand factor 6, 7
  • Both surgical AVR and TAVR can correct this acquired deficiency 7, 8
  • If you have suspected hereditary von Willebrand disease, this doesn't preclude either approach, but TAVR has been successfully performed in patients with von Willebrand disease 9
  • The bleeding risk from your von Willebrand disease may actually favor the less invasive ViV approach if your surgical risk is elevated

What Your Team Is Likely Thinking

If they're leaning toward ViV, it's probably because:

  • They've assessed your surgical risk as high or prohibitive
  • Your anatomy on preliminary imaging looks favorable for ViV
  • They want to avoid the risks of re-do sternotomy (second open-heart surgery is higher risk than first)
  • Your von Willebrand disease may increase bleeding risk with surgery

However, at age 34, they should seriously consider:

  • Whether you're truly high surgical risk or if this is just preference
  • The likelihood you'll outlive the ViV valve durability
  • Whether a mechanical valve (which lasts forever but requires lifelong blood thinners) might be better via surgery

The Algorithm for Your Decision

After your CT scan, the decision tree looks like this:

  1. If CT shows you're NOT a ViV candidate (unfavorable anatomy, high coronary obstruction risk, need for aortic root replacement):

    • → Surgical AVR is your only option
    • → Consider mechanical valve given your young age (requires warfarin lifelong)
    • → Or another bioprosthetic valve (will need replacement again in 10-15 years)

  2. If CT shows you ARE a ViV candidate AND you're high/prohibitive surgical risk:

    • → ViV is reasonable 1
    • → Accept that you'll likely need another intervention in 10-15 years
    • → Plan for potential future valve-in-valve-in-valve or surgery

  3. If CT shows you ARE a ViV candidate BUT you're low-to-moderate surgical risk:

    • → Surgical AVR is likely better for long-term outcomes 1
    • → Seriously discuss mechanical valve option (no reoperations needed)
    • → If you refuse mechanical valve, surgical bioprosthetic gives better hemodynamics than ViV

Common Pitfalls to Avoid

  • Don't assume ViV is "easier" just because it's less invasive—at your age, you need to think about lifetime strategy
  • Don't let fear of open-heart surgery drive you to ViV if you're a good surgical candidate—the long-term outcomes favor surgery in younger patients
  • Don't skip the CT scan—it's essential for safety and planning regardless of which approach you choose
  • Don't forget to discuss mechanical valves—yes, they require warfarin, but you'd never need another valve replacement

Bottom Line

Get the CT scan first—it will determine if ViV is even anatomically possible. If you're a ViV candidate, the choice between ViV and surgery depends heavily on your surgical risk assessment. At 34 years old, if you're a reasonable surgical candidate, open-heart surgery with either a mechanical valve (best durability) or surgical bioprosthetic valve (better hemodynamics than ViV) is likely the better long-term strategy 2, 1, 2. However, if your surgical risk is truly high or prohibitive, ViV is a reasonable option that can be performed safely even with your von Willebrand disease 1, 9.

References

8
Research

Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosis.

Haemophilia : the official journal of the World Federation of Hemophilia, 2023

Related Questions

Can a transthoracic echocardiogram miss aortic regurgitation?
How far in advance should desmopressin (DDAVP) be administered to a patient with von Willebrand disease undergoing a dental procedure?
As a 34‑year‑old with suspected von Willebrand disease and a failing 12‑year‑old porcine bioprosthetic valve, should I obtain definitive von Willebrand testing before deciding between a valve‑in‑valve transcatheter replacement or open‑heart surgery with a mechanical valve, and what factors should guide this choice?
What are the indications for aortic valve replacement (AVR) in severe aortic regurgitation?
Should tranexamic acid (Amicar) be given prior to orthopedic surgery in patients with von Willebrand disease?
What are the possible causes of elevated jugular venous pressure?
Has the patient with PD‑L1‑positive gallbladder cancer already received all standard chemotherapy options, including gemcitabine‑cisplatin, FOLFOX, and other fluoropyrimidine‑ or irinotecan‑based regimens?
In a 66‑year‑old female with major depressive disorder (recurrent, moderate), generalized anxiety disorder, insomnia, dysarthria and cognitive deficits following cerebral infarction, who is taking escitalopram 5 mg daily, mirtazapine 15 mg at bedtime, trazodone 100 mg at bedtime, memantine 5 mg daily, and cholecalciferol 5000 IU daily, and reports persistent trouble sleeping after an ineffective trial of cognitive‑behavioral therapy, what safe pharmacologic intervention can be used to improve her sleep?
Is it safe to take sulindac and naproxen together?
What do a cerebrospinal fluid glucose of 112 mg/dL and protein of 30 mg/dL indicate?
In a patient with impaired concentration and a TSH of 12.3 mIU/L, what initial dose of levothyroxine (Synthroid) should be started?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.